Compare Bank of Nova Scotia (BNS) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Nova Scotia vs BIO-TECHNE Corp — how do they compare? Bank of Nova Scotia trades at $89.04 (market cap $107.49B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: Bank of Nova Scotia is far larger — about 9.7× BIO-TECHNE Corp's market cap, and Bank of Nova Scotia pays the higher dividend (3.65%). Which is the better fit depends on your goals.
| BNS | TECH | |
|---|---|---|
Market Cap | $107.49B | $11.12B |
Sector | Financials | Health |
52-Week High | $88.99 | $71.38 |
52-Week Low | $54.50 | $43.31 |
Dividend Yield | 3.65% | 0.45% |
Enterprise Value | — | $11.20B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bank of Nova Scotia
Bank of Nova Scotia is a global financial services provider. The bank has five business segments: Canadian banking, international banking, global wealth management, global banking and markets, and other. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in Central and South America.
Read more on BNS →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
